In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Axovan Ltd. completes $18.3mm in second round

Executive Summary

Through a second round private placement, Axovan Ltd. completed (Euro20.5mm), $18.3mm in equity financing. The lead investor for the placement was Atlas Venture. New investors included Heidelberg Innovation, NeoMed, Banque Cantonale Vaudoise Private Equity and all existing investors in the company.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies